N/C(=N\O)c1cn([C@@H]2O[C@@H](CO)[C@H](O)[C@@H]2O)c2ncnc(NO)c12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?